![ALLO-501A](https://www.adcreviews.com/wp-content/uploads/2022/10/ALLO-501A-240x125.jpg)
Allogene launches first allogeneic CAR-T phase II trial
On October 6, Allogene announced the initiation of the Phase II ALPHA2 trial of the investigational allogeneic CAR T therapy ALLO-501A for the treatment of
On October 6, Allogene announced the initiation of the Phase II ALPHA2 trial of the investigational allogeneic CAR T therapy ALLO-501A for the treatment of